Login

Enzymatica presents positive in-vitro results | August 2023 - Claus Egstrand,CEO, Enzymatica AB (publ) 00:00:00

Share On Facebook Share On Twitter

Enzymatica presents positive in-vitro results | August 2023

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Join DAC Technologies: Seeking Senior Controls Engineer for Innovative Projects and Competitive Benefits
00:10:00
Identifying Value in Today's Global Credit Markets: Insights Live with Oaktree's Leading Experts
00:10:00
Jean-Marc Lulan Discusses Azimut Exploration's Diverse Portfolio, Major Partnerships, and Upcoming Drilling Programs
00:10:00
Cherry Picking, Selektion og Ledelse: En Diskussion med Morten Chrone fra Brødrene A & O Johansen A/S
00:10:00
Advancing Space Communication: Optical Laser Technology in Next-Generation Satellite Fleets |Bulent Altan , CEO , Mynaric AG.
00:10:00
Introducing Gerald Pötzsch, the new CEO of ContextVision, discussing his decision to join the company and what makes ContextVision a standout in its field.|Gerald Pötzsch joined ContextVision in August 2022 as CEO.
00:10:00
Shaping the Future of Asset Management: Insights from Peter Harrison of Schroders | Peter Harrison - CEO, Schroders
00:10:00
CEO Marita Zuraitis discusses leadership as Horace Mann announces the Principals of the Year award recipients.
00:10:00
making early bets on Facebook Slack Dropbox Spotify and more|Amit Kumar,Partner,Accel
00:00:00
Advanced Oncotherapy present research potentially offering 'powerful weapon to resistant cancers' - Jonathan Farr, Chief Clinical Officer, Advanced Oncotherapy
00:10:00
Breaking the Stigma: Addressing Mental Health and Addiction in the Workplace | Christopher J. Swift, CEO , The Hartford.
00:10:00
Exploring Innovations in Cancer Immunotherapy|Søren Bregenholt, CEO, Alligator Bioscience AB.

© 2017 - Neuhu+